My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Immunic, Inc. - Common Stock (NQ:IMUX)

0.7622 +0.0522 (+7.35%)

Streaming Delayed Price Updated: 1:36 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

September 29, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...

Via Benzinga

This VSE Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

September 29, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...

Via Benzinga

Immunic (IMUX) Q2 Loss Widens 25% ↗

August 07, 2025

Via The Motley Fool

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial ↗

July 07, 2025

Via Stocktwits

Immunic to Participate in Scientific and Industry Conferences in May ↗

July 07, 2025

Via Stocktwits

Topics Economy

Immunic, Inc. Announces Proposed Public Offering ↗

July 07, 2025

Via Stocktwits

Topics Regulatory Compliance

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering ↗

July 07, 2025

Via Stocktwits

Immunic to Participate in Investor, Scientific and Industry Conferences in June ↗

July 02, 2025

Via Stocktwits

Topics Intellectual Property

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering ↗

July 02, 2025

Via Stocktwits

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS ↗

July 02, 2025

Via Stocktwits

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis ↗

July 02, 2025

Via Stocktwits

Let's take a look at the stocks that are in motion in today's session. ↗

May 29, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 28, 2025

Via Benzinga

Wednesday's session: top gainers and losers ↗

April 30, 2025

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

April 30, 2025

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

These stocks that are showing activity before the opening bell on Wednesday. ↗

April 30, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 30, 2025

Via Benzinga

Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode ↗

April 09, 2025

Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.

Via Stocktwits

Topics Intellectual Property Lawsuit

Immunic to Present at the November 21st Virtual Investor Summit Microcap Event

November 11, 2024

Via ACCESSWIRE

This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday ↗

September 16, 2024

Via Benzinga

Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying ↗

May 23, 2024

While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying.

Via InvestorPlace

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

May 20, 2024

Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20.

Via TheNewswire.com

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

May 20, 2024

Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day

Via News Direct

Immunic chief medical officer discusses promising treatments to mark World IBD Day

May 17, 2024

Immunic chief medical officer discusses promising treatments to mark World IBD Day

Via News Direct

Immunic chief medical officer discusses promising treatments to mark World IBD Day

May 17, 2024

Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19.

Via TheNewswire.com

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day

May 16, 2024

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day

Via News Direct

Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day

May 16, 2024

Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease...

Via TheNewswire.com

Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones

May 09, 2024

Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones

Via News Direct

Topics Intellectual Property

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition